Skip to content

Evaluation of two-step irradiance schedule in aminolevulinic acid-based photodynamic therapy on clinical applications and safety for condyloma acuminatum and acne

Evaluation of two-step irradiance schedule in aminolevulinic acid-based photodynamic therapy on clinical applications and safety for condyloma acuminatum and acne

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100041763
Enrollment
Unknown
Registered
2021-01-04
Start date
2021-01-03
Completion date
Unknown
Last updated
2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

condyloma acuminatum and acne

Interventions

Group A (condyloma acuminatum):Two-step irradiance schedule
Group B (condyloma acuminatum):Conventional treatment
Group C (acne):Two-step irradiance schedule
Group D (acne):Conventional treatment

Sponsors

The Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Clinical diagnosed with condyloma acuminatum or acne, aged > 18 years; 2. All patients voluntarily participate in the study, actively cooperate with the treatment and ability to understand and the willingness to sign a written informed consent. Patients are willing to pay for the treatment, and agreed to take a picture of the skin lesions.

Exclusion criteria

Exclusion criteria: 1. Those who have been treated with ALA-PDT and those who have applied any other impact study within 12 weeks; 2. Patients with other diseases that may affect the efficacy evaluation, such as other light skin diseases; 3. Patients taking phototoxic or photosensitive drugs within 12 weeks; 4. Patients with severe immune dysfunction; 5. Patients with scar constitution; 6. Patients with known skin photoallergy, porphyria or allergy to Ala, light or lidocaine; 7. Those who suffer from serious internal diseases, psychological and mental diseases, infectious diseases or pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
complete clearance rate of condyloma acuminatum lesions;complete clearance rate of acne lesions;

Secondary

MeasureTime frame
Pain assessment;Recurrence rate of lesions;

Countries

China

Contacts

Public ContactGuan Jiang

The Affiliated Hospital of Xuzhou Medical University

dr.guanjiang@xzhmu.edu.cn+86 13013941798

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026